GlassScriptPhysician profile
R Michael Tucker
NPI 1497742936
$9,829.50
in general payments reported to CMS, 2019-2025
43 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $1,155 · 2021: $1,263 · 2022: $1,017 · 2023: $1,798 · 2024: $1,989 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,357.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,395.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $945.16 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $822.71 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $692.85 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Novartis Pharmaceuticals Corporation | $637.78 | 2019-2025 | |
| Amgen INC. | $625.04 | 2019-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $547.78 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Kestra Medical Technology Services, INC. | $409.12 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $408.13 | 2019-2024 | Xarelto |
| Sunovion Pharmaceuticals INC. | $400.33 | 2019-2021 | |
| Pfizer INC. | $388.08 | 2020-2025 | |
| Astellas Pharma US INC | $323.90 | 2019-2025 | Veozah |
| Dexcom, INC. | $277.80 | 2021-2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $228.61 | 2019-2022 | |
| Esperion Therapeutics, INC. | $225.07 | 2020-2025 | Nexletol |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw R Michael Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.